Compile Data Set for Download or QSAR
Report error Found 920 Enz. Inhib. hit(s) with all data for entry = 11096
LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 48 | ...)
Affinity DataIC50: 0.0500nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 48 | ...)
Affinity DataIC50: 0.120nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 48 | ...)
Affinity DataIC50: 0.220nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589895(US11559538, Example 147 | US11559538, Example 148)
Affinity DataIC50: 0.240nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589886(US11559538, Example 138 | US11559538, Example 139 ...)
Affinity DataIC50: 0.25nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50: 0.280nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589754(US11559538, Example 17 | US11559538, Example 50)
Affinity DataIC50: 0.280nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589830(US11559538, Example 84 | US11559538, Example 85)
Affinity DataIC50: 0.290nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterleukin-4(Human)
Pfizer

US Patent
LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50: 0.290nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50: 0.330nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50: 0.340nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50: 0.340nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589782(US11559538, Example 42)
Affinity DataIC50: 0.350nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterleukin-4(Human)
Pfizer

US Patent
LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50: 0.360nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589780(US11559538, Example 40)
Affinity DataIC50: 0.370nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589886(US11559538, Example 138 | US11559538, Example 139 ...)
Affinity DataIC50: 0.400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589895(US11559538, Example 147 | US11559538, Example 148)
Affinity DataIC50: 0.440nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589830(US11559538, Example 84 | US11559538, Example 85)
Affinity DataIC50: 0.440nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589811(US11559538, Example 68)
Affinity DataIC50: 0.470nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589754(US11559538, Example 17 | US11559538, Example 50)
Affinity DataIC50: 0.470nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589897(US11559538, Example 149)
Affinity DataIC50: 0.490nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589740(US11559538, Example 4 | US20240083921, Compound A)
Affinity DataIC50: 0.5nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589839(US11559538, Example 93)
Affinity DataIC50: 0.5nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589776(US11559538, Example 34)
Affinity DataIC50: 0.520nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589958(US11559538, Example 205)
Affinity DataIC50: 0.520nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50: 0.530nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50: 0.530nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterleukin-4(Human)
Pfizer

US Patent
LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 48 | ...)
Affinity DataIC50: 0.540nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589821(US11559538, Example 78 | US11559538, Example 79 | ...)
Affinity DataIC50: 0.550nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589825(US11559538, Example 81 | US11559538, Example 82)
Affinity DataIC50: 0.550nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589830(US11559538, Example 84 | US11559538, Example 85)
Affinity DataIC50: 0.560nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589892(US11559538, Example 144)
Affinity DataIC50: 0.580nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589758(US11559538, Example 21 | US11559538, Example 189 |...)
Affinity DataIC50: 0.600nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589856(US11559538, Example 110)
Affinity DataIC50: 0.610nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterleukin-4(Human)
Pfizer

US Patent
LigandPNGBDBM589760(US11559538, Example 23 | US11559538, Example 124 |...)
Affinity DataIC50: 0.610nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589743(US11559538, Example 7 | US11559538, Example 36 | U...)
Affinity DataIC50: 0.630nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589758(US11559538, Example 21 | US11559538, Example 189 |...)
Affinity DataIC50: 0.640nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589919(US11559538, Example 167 | US11559538, Example 168)
Affinity DataIC50: 0.640nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterleukin-4(Human)
Pfizer

US Patent
LigandPNGBDBM589754(US11559538, Example 17 | US11559538, Example 50)
Affinity DataIC50: 0.650nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589738(US11559538, Example 2)
Affinity DataIC50: 0.670nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589933(US11559538, Example 181)
Affinity DataIC50: 0.680nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589867(US11559538, Example 121)
Affinity DataIC50: 0.690nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589739(US11559538, Example 3)
Affinity DataIC50: 0.700nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589743(US11559538, Example 7 | US11559538, Example 36 | U...)
Affinity DataIC50: 0.710nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589751(US11559538, Example 15 | US11559538, Example 47)
Affinity DataIC50: 0.710nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589808(US11559538, Example 65 | US11559538, Example 67 | ...)
Affinity DataIC50: 0.710nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetInterferon gamma receptor 1(Human)
Pfizer

US Patent
LigandPNGBDBM589742(US11559538, Example 6 | US11559538, Example 35 | U...)
Affinity DataIC50: 0.720nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589802(US11559538, Example 58 | US11559538, Example 194)
Affinity DataIC50: 0.720nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589864(US11559538, Example 118 | US11559538, Example 119)
Affinity DataIC50: 0.720nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50: 0.720nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

Displayed 1 to 50 (of 920 total ) | Next | Last >>
Jump to: